About IBA
IBA is a company founded in 1986 by Yves Jongen. It operates as a Professional Services, and Direct-to-Consumer (D2C). IBA has raised $27.32 million across 11 funding rounds from investors including European Union, SRIW and SFPIM. The company has 26 employees as of March 28, 2024. IBA has completed 3 acquisitions, including Modus QA, PhantomX and Radcal. IBA offers products and services including Proton Therapy, Dosimetry Solutions, RadioPharma Solutions, and Industrial Solutions. IBA operates in a competitive market with competitors including Oxford Instruments, Nanox, Leica Microsystems, SpectraWAVE and Adaptix, among others.
- Employees 26 as on 28 Mar, 2024
- Founders Yves Jongen
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Iba Worldwide
- Date of Incorporation 24 Dec, 2004
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$4.73 M (USD)23.52as on Mar 31, 2023
-
Net Profit
$692.78 K (USD)54.63as on Mar 31, 2023
-
EBITDA
$1.05 M (USD)51.05as on Mar 31, 2023
-
Total Equity Funding
$27.32 M (USD)
in 11 rounds
-
Latest Funding Round
$260.73 K (USD), Grant
Nov 16, 2021
-
Investors
European Union
& 2 more
-
Employee Count
26
as on Mar 28, 2024
-
Investments & Acquisitions
Modus QA
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IBA
IBA offers a comprehensive portfolio of products and services, including Proton Therapy, Dosimetry Solutions, RadioPharma Solutions, and Industrial Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced cancer treatment using proton beam technology is provided.
Quality assurance tools for radiation therapy are offered.
Radiochemistry and cyclotron solutions for diagnostics are developed.
Sterilization solutions for medical devices are engineered.
Unlock access to complete
Unlock access to complete
Software Development Team
56 people
Product Management Team
27 people
R Team
23 people
Leadership Team
20 people
Field Team
15 people
Human Resources and Administration
14 people
Sales and Marketing
11 people
Creative and Marketing Team
9 people
Unlock access to complete
Funding Insights of IBA
IBA has successfully raised a total of $27.32M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $260.73 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $260,729
-
First Round
First Round
(30 Jun 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Grant - IBA | Valuation |
investors |
|
| Aug, 2020 | Amount | Grant - IBA | Valuation |
investors |
|
| Jun, 2018 | Amount | Grant - IBA | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IBA
IBA has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SRIW and SFPIM. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are pursued by SRIW as a private equity firm.
|
Founded Year | Domain | Location | |
|
Private equity is directed toward private and public companies.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IBA
IBA has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Modus QA, PhantomX and Radcal. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provides realistic phantoms for medical imaging, AI training, and diagnostic testing.
|
2021 | ||||
|
Advanced radiotherapy and medical imaging devices are manufactured.
|
2000 | ||||
|
Diagnostic X-ray imaging solutions are provided for medical practitioners.
|
1980 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - IBA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Iba Comparisons
Competitors of IBA
IBA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Nanox, Leica Microsystems, SpectraWAVE and Adaptix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Technology tools and systems for molecular scale are developed.
|
|
| domain | founded_year | HQ Location |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
|
|
| domain | founded_year | HQ Location |
Imaging solutions for macro, micro, and nano structures are provided.
|
|
| domain | founded_year | HQ Location |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| domain | founded_year | HQ Location |
Planar X-ray radiology products for diagnostic imaging are supplied.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Iba
Frequently Asked Questions about IBA
When was IBA founded?
IBA was founded in 1986 and raised its 1st funding round 28 years after it was founded.
Is IBA a funded company?
IBA is a funded company, having raised a total of $27.32M across 11 funding rounds to date. The company's 1st funding round was a Grant of $1.66M, raised on Jun 30, 2014.
How many employees does IBA have?
As of Mar 28, 2024, the latest employee count at IBA is 26.
What is the annual revenue of IBA?
Annual revenue of IBA is $4.73M as on Mar 31, 2023.
What does IBA do?
Solutions for cancer diagnosis and treatment are designed and marketed by IBA, focusing on proton therapy and dosimetry. Industrial applications such as medical device sterilization are also addressed. Sectors including healthcare and industrial technology are served with advanced equipment and services. Integrated radiopharma solutions and cyclotrons are developed for medical imaging and diagnostics. Sustainability and scientific innovation are emphasized through the IBA Discovery Lab.
Who are the top competitors of IBA?
IBA's top competitors include Oxford Instruments, Adaptix and Nanox.
What products or services does IBA offer?
IBA offers Proton Therapy, Dosimetry Solutions, RadioPharma Solutions, and Industrial Solutions.
How many acquisitions has IBA made?
Who are IBA's investors?
IBA has 3 investors. Key investors include European Union, SRIW, and SFPIM.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.